Bill Ackman Details Plan to Take Hedge-Fund Firm, New Fund Public Simultaneously
The billionaire investor's unique double listing is an attempted do-over of a botched 2024 offering of the new investment fund.
----
FDA Warns Novo Nordisk of Unreported Side Effects Tied to GLP-1 Patients
The FDA underscored cases including two deaths and a suicide linked to patients taking semaglutide, which Novo markets as Ozempic and Wegovy.
----
Meta to Acquire AI-Only Social Media Platform Moltbook
Moltbook's team will join Meta's Superintelligence Labs division in the tech giant's latest move to scale up its AI-related talent and capabilities.
----
Former Meta AI Pioneer Yann LeCun Raises Over $1 Billion for New Startup
Advanced Machine Intelligence seeks to develop a new breed of AI systems that can better understand the real world than existing models.
----
Boeing Says Wiring Flaws Will Slow Some 737 MAX Deliveries
The company found scratched wiring in undelivered planes and said the delay could curb overall plane deliveries this month.
----
Saudi Arabia Pushes East-West Pipeline Toward Capacity Amid Hormuz Disruption
Saudi Aramco says crude flows through the pipeline network should reach its 7 million-barrel-a-day capacity within days, up from about 2.8 million barrels a day before the Iran war.
----
Australian Plastics Recycling Company Targets Critical Minerals
Samsara Eco plans to tailor microscopic organisms to retrieve materials from electronic waste.
----
Exxon Mobil Plans to Move Its Legal Home to Texas From New Jersey
With shareholder approval, the company, incorporated in New Jersey since 1882, would join other firms seeking a more business-friendly environment.
----
BioNTech Shares Fall After Co-Founders Plan Exit and Outlook Misses Forecasts
With sales of Covid-19 shots dwindling, the biotech company is looking to accelerate efforts to develop new products.
----
Nvidia Invests in Mira Murati's Thinking Machines Lab
The startup, founded by OpenAI's former CTO, plans to deploy at least one gigawatt of Nvidia chips as part of a new partnership.
----
FDA Approves Drug Trump Touted for Autism to Treat Other Neurological Disorder
The Food and Drug Administration approved leucovorin to treat a neurological disorder with some symptoms similar to autism.
----
European Space Merger Faces Pushback From Local Competitors
The friction points to potential hurdles in the regulatory process that awaits Airbus, Leonardo and Thales to get their space merger over the line.
----
Kohl's Turnaround Stalls in Fourth Quarter, But CEO Remains Upbeat on Progress
CEO Michael Bender said the department-store chain ended 2025 on stronger footing than when the year started, even if results in the recent quarter were softer than expected.
----
Renault to Refresh Car Lineup in International Push
The carmaker plans to launch 36 new models by the end of this decade, as it looks beyond Europe to drive growth.
----
NIO Turns First Profit on Record Sales, Strong Margins
The company joins the small but growing ranks of profitable electric-vehicle makers in the world's largest auto market.
(END) Dow Jones Newswires
March 10, 2026 15:00 ET (19:00 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.